The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
Abbonati Chemicals
|
EN | 5803 kB | 3 |
ID 6331 | Ed. 15.0 2024 del 02 Settembre 2024 / Suddiviso in 12 sezioni
Raccolta di tutta la disciplina normativa europea (Pacchetto igiene...
ID 20827 | 23.11.2023
Rettifica del regolamento delegato (UE) 2020/217 della Commissione, del 4 ottobre 2019, che modifica, ai fini dell'adeguamento al progr...
In 1996, a serious incident focused the attention of the gas industry on the fact that a cryogenic storage tank can be press...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024